Found 135 matching trials
Phase II Study of Everolimus Beyond Progression PHASE2 This phase II trial studies how well everolimus and hormone therapy work in...
Show More Location
Emory University Hospital Midtown
Learn More & Join Trial
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis PHASE2 This phase II trial studies how well radiation therapy given with standard ...
Show More Location
Grady Health System
Learn More & Join Trial
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer PHASE1 This phase Ib trials studies the side effects and how well talimogene laher...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer PHASE2 This phase II trial studies the side effects and how well palbociclib and l...
Show More Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer PHASE2 This phase II trial tests the accuracy of functional imaging (FFNP)-positro...
Show More Location
Siteman Cancer Center at Washington University
Learn More & Join Trial
Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy PHASE3 RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone th...
Show More Location
Federico II University Medical School
Learn More & Join Trial
A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer PHASE1 This study aims to evaluate the safety, tolerability, efficacy and pharmaco...
Show More Location
The Second Affiliated Hospital of Dalian Medical University
Learn More & Join Trial
Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer PHASE2 Primary Objective:
To determine whether amcenestrant per overall survival ...
Show More Location
Alabama Oncology - St. Vincent's Birmingham- Site Number : 8400008
Learn More & Join Trial
Study of PF-07248144 in Advanced or Metastatic Solid Tumors PHASE2 This is an open-label, multi center study to evaluate safety, tolerability,...
Show More Learn More & Join Trial
A Study of Abemaciclib in Indian Women With Advanced Breast Cancer PHASE4 The main purpose of this study is to learn more about the safety and tolera...
Show More Location
MNJ Institute of Oncology
Learn More & Join Trial